Ethambutol hydrochloride and Rash erythematous - a phase IV clinical study of FDA data

Summary:

Rash erythematous is found among people who take Ethambutol hydrochloride, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Ethambutol hydrochloride and have Rash erythematous. It is created by eHealthMe based on reports of 2,485 people who have side effects when taking Ethambutol hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

2,485 people reported to have side effects when taking Ethambutol hydrochloride.
Among them, 16 people (0.64%) have Rash erythematous.


What is Ethambutol hydrochloride?

Ethambutol hydrochloride has active ingredients of ethambutol hydrochloride. It is often used in tuberculosis. eHealthMe is studying from 2,581 Ethambutol hydrochloride users for its effectiveness, alternative drugs and more.

What is Rash erythematous?

Rash erythematous (redness of the skin) is found to be associated with 2,531 drugs and 1,817 conditions by eHealthMe.

Number of Ethambutol hydrochloride and Rash erythematous reports submitted per year:

Could Ethambutol hydrochloride cause Rash erythematous?

Gender of people who have Rash erythematous when taking Ethambutol hydrochloride *:

  • female: 25 %
  • male: 75 %

Age of people who have Rash erythematous when taking Ethambutol hydrochloride *:

  • 0-1: 14.29 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.14 %
  • 30-39: 21.43 %
  • 40-49: 21.43 %
  • 50-59: 14.29 %
  • 60+: 21.43 %

Common drugs people take besides Ethambutol hydrochloride *:

  1. Isoniazid: 12 people, 75.00%
  2. Pyrazinamide: 10 people, 62.50%
  3. Rifampin: 5 people, 31.25%
  4. Fludarabine Phosphate: 2 people, 12.50%
  5. Cyclosporine: 2 people, 12.50%
  6. Tacrolimus: 2 people, 12.50%
  7. Acyclovir: 2 people, 12.50%
  8. Mefenamic Acid: 2 people, 12.50%
  9. Fluconazole: 2 people, 12.50%
  10. Dexamethasone: 2 people, 12.50%

Common side effects people have besides Rash erythematous *:

  1. Fever: 9 people, 56.25%
  2. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 8 people, 50.00%
  3. Alanine Aminotransferase Increased: 5 people, 31.25%
  4. Aspartate Aminotransferase Increased: 4 people, 25.00%
  5. White Blood Cell Count Increased: 3 people, 18.75%
  6. Drug Hypersensitivity: 3 people, 18.75%
  7. Paleness (unusual lightness of skin colour): 3 people, 18.75%
  8. Haemoglobin Decreased: 3 people, 18.75%
  9. Haematemesis (vomiting of blood): 3 people, 18.75%
  10. Rash Pruritic (redness with itching): 3 people, 18.75%

Common conditions people have *:

  1. Pulmonary Tuberculosis (lungs tuberculosis): 3 people, 18.75%
  2. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 12.50%
  3. Acne (skin problems that cause pimples): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ethambutol hydrochloride and have Rash erythematous?

Check whether Rash erythematous is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Rash erythematous and when was it recovered:

Expand to all the drugs that have ingredients of ethambutol hydrochloride:

Alternative drugs to, pros and cons of Ethambutol hydrochloride:

Common Ethambutol hydrochloride side effects:

Browse all side effects of Ethambutol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Rash erythematous treatments and more:

COVID vaccines that are related to Rash erythematous:

Common drugs associated with Rash erythematous:

All the drugs that are associated with Rash erythematous:

Common conditions associated with Rash erythematous:

All the conditions that are associated with Rash erythematous:

How the study uses the data?

The study uses data from the FDA. It is based on ethambutol hydrochloride (the active ingredients of Ethambutol hydrochloride) and Ethambutol hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: